February 14, 2018 / 1:33 PM / 2 months ago

BRIEF-Avadel Pharmaceuticals Announces Pricing Of $125 Mln 4.50 Pct Exchangeable Senior Notes

Feb 14 (Reuters) - Avadel Pharmaceuticals Plc:

* AVADEL PHARMACEUTICALS ANNOUNCES PRICING OF $125.0 MILLION 4.50% EXCHANGEABLE SENIOR NOTES DUE 2023

* AVADEL PHARMACEUTICALS - 2023 NOTES WILL BE EXCHANGEABLE AT OPTION OF HOLDERS AT INITIAL EXCHANGE RATE OF 92.6956 ADSS/$1,000 PRINCIPAL AMOUNT OF NOTES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below